Equity Research, Broker Reports, and media content on Oncimmune Holdings Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oncimmune Holdings Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Oncimmune Holdings Plc

Company Profile

  • Personnel
  • Adam Hill, CEO
  • Matthew Hall, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oncimmune Holdings Plc. We currently have 72 research reports from 7 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 30.0/200p
  • Daily Volume: N/A
  • Daily Liquidity: (0.07%)
  • # Shares: 63.5m
  • Market Cap: £112.8m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
21Oct20 07:00 RNS-R Abstracts of Studies using EarlyCDT Lung
19Oct20 08:21 RNS Replacement: Notice of Full Year Results
19Oct20 07:00 RNS Notice of Full Year Results ended 31 May 2020
13Oct20 07:00 RNS Agreement with Cedars-Sinai to Profile COVID-19
08Oct20 11:05 RNS Second Price Monitoring Extn
08Oct20 11:00 RNS Price Monitoring Extension
06Oct20 07:00 RNS UK Government funding for tool for use in COVID-19
  • Frequency of research reports

     

  • Research reports on

    Oncimmune Holdings Plc

  • Providers covering

    Oncimmune Holdings Plc